Antibody response after vaccination against SARS-CoV-2 in adults with hematological malignancies: a systematic review and meta-analysis

Vaccines against SARS-CoV-2 have shown remarkable efficacy and thus constitute an important preventive option against coronavirus disease 2019 (COVID-19), especially in fragile patients. We aimed to systematically analyze the outcomes of patients with hematological malignancies who received vaccinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagelmann, Nico, Passamonti, Francesco, Wolschke, Christine, Massoud, Radwan, Niederwieser, Christian, Adjallé, Raissa, Mora, Barbara, Ayuk, Francis, Kröger, Nicolaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Article - Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335098/
https://www.ncbi.nlm.nih.gov/pubmed/34911284
http://dx.doi.org/10.3324/haematol.2021.280163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335098/
https://www.ncbi.nlm.nih.gov/pubmed/34911284
http://dx.doi.org/10.3324/haematol.2021.280163

Ejemplares similares